- Home
- VIR vs GES Comparison
VIR vs GES Comparison
Compare VIR & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- GES
- Stock Information
- Founded
- VIR 2016
- GES 1981
- Country
- VIR United States
- GES Switzerland
- Employees
- VIR N/A
- GES N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- GES Apparel
- Sector
- VIR Health Care
- GES Consumer Discretionary
- Exchange
- VIR Nasdaq
- GES Nasdaq
- Market Cap
- VIR 706.4M
- GES 872.4M
- IPO Year
- VIR 2019
- GES 1996
- Fundamental
- Price
- VIR $5.90
- GES $16.82
- Analyst Decision
- VIR Strong Buy
- GES Buy
- Analyst Count
- VIR 11
- GES 5
- Target Price
- VIR $25.73
- GES $19.25
- AVG Volume (30 Days)
- VIR 1.3M
- GES 569.4K
- Earning Date
- VIR 10-30-2025
- GES 11-25-2025
- Dividend Yield
- VIR N/A
- GES 5.34%
- EPS Growth
- VIR N/A
- GES N/A
- EPS
- VIR N/A
- GES 0.35
- Revenue
- VIR $19,000,000.00
- GES $3,091,508,000.00
- Revenue This Year
- VIR N/A
- GES $7.97
- Revenue Next Year
- VIR $15.25
- GES $3.46
- P/E Ratio
- VIR N/A
- GES $48.56
- Revenue Growth
- VIR N/A
- GES 7.84
- 52 Week Low
- VIR $4.16
- GES $8.48
- 52 Week High
- VIR $14.45
- GES $19.91
- Technical
- Relative Strength Index (RSI)
- VIR 57.82
- GES 61.91
- Support Level
- VIR $5.71
- GES $16.75
- Resistance Level
- VIR $6.17
- GES $16.94
- Average True Range (ATR)
- VIR 0.32
- GES 0.10
- MACD
- VIR -0.01
- GES -0.07
- Stochastic Oscillator
- VIR 53.17
- GES 60.00
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About GES Guess? Inc.
Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.